Compare Glenmark Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs ZIM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA ZIM LABORATORIES GLENMARK PHARMA/
ZIM LABORATORIES
 
P/E (TTM) x 13.4 49.1 27.3% View Chart
P/BV x 1.9 1.4 144.0% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GLENMARK PHARMA   ZIM LABORATORIES
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-21
ZIM LABORATORIES
Mar-20
GLENMARK PHARMA/
ZIM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs573149 384.6%   
Low Rs19542 465.0%   
Sales per share (Unadj.) Rs387.8171.7 225.9%  
Earnings per share (Unadj.) Rs34.42.0 1,687.2%  
Cash flow per share (Unadj.) Rs50.110.9 457.8%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs249.694.8 263.2%  
Shares outstanding (eoy) m282.1716.18 1,743.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.00.6 178.0%   
Avg P/E ratio x11.246.9 23.8%  
P/CF ratio (eoy) x7.78.7 87.9%  
Price / Book Value ratio x1.51.0 152.9%  
Dividend payout %7.30-   
Avg Mkt Cap Rs m108,3531,544 7,015.6%   
No. of employees `000NANA-   
Total wages/salary Rs m23,437514 4,562.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m109,4392,777 3,940.4%  
Other income Rs m50245 1,110.7%   
Total revenues Rs m109,9412,823 3,895.0%   
Gross profit Rs m21,289226 9,414.2%  
Depreciation Rs m4,436144 3,077.7%   
Interest Rs m3,531127 2,790.3%   
Profit before tax Rs m13,8251 2,003,587.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,124-32 -12,775.3%   
Profit after tax Rs m9,70133 29,423.4%  
Gross profit margin %19.58.1 238.9%  
Effective tax rate %29.8-4,678.3 -0.6%   
Net profit margin %8.91.2 746.8%  
BALANCE SHEET DATA
Current assets Rs m73,5961,820 4,043.0%   
Current liabilities Rs m42,0101,434 2,928.9%   
Net working cap to sales %28.913.9 207.7%  
Current ratio x1.81.3 138.0%  
Inventory Days Days716 40.7%  
Debtors Days Days8689 96.1%  
Net fixed assets Rs m67,0931,379 4,863.8%   
Share capital Rs m282162 174.4%   
"Free" reserves Rs m70,1481,373 5,109.7%   
Net worth Rs m70,4301,535 4,589.4%   
Long term debt Rs m38,888274 14,182.4%   
Total assets Rs m140,6893,200 4,396.9%  
Interest coverage x4.91.0 488.9%   
Debt to equity ratio x0.60.2 309.0%  
Sales to assets ratio x0.80.9 89.6%   
Return on assets %9.45.0 188.7%  
Return on equity %13.82.1 641.2%  
Return on capital %15.97.0 225.7%  
Exports to sales %057.6 0.0%   
Imports to sales %04.6 0.0%   
Exports (fob) Rs mNA1,600 0.0%   
Imports (cif) Rs mNA128 0.0%   
Fx inflow Rs m35,7531,697 2,107.1%   
Fx outflow Rs m12,023128 9,393.2%   
Net fx Rs m23,7291,569 1,512.6%   
CASH FLOW
From Operations Rs m11,312219 5,161.8%  
From Investments Rs m-6,752-191 3,542.9%  
From Financial Activity Rs m-4,418-25 17,607.8%  
Net Cashflow Rs m27810 2,891.9%  

Share Holding

Indian Promoters % 46.7 33.3 140.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 35.0 0.0 -  
FIIs % 25.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 66.7 79.9%  
Shareholders   329,870 4,610 7,155.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   UNICK FIX-A-FORM AND PRINTERS  SOLARA ACTIVE PHARMA SCIENCES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  SANJIVANI PA  



Today's Market

Sensex Trades Marginally Higher, Dow Futures Trade Flat(12:30 pm)

Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 218 points, up 0.4%, at 61,039 levels.

Related Views on News

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Oct 25, 2021 03:36 PM

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 8-QTR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS